IRCT20220207053961N1尚未招募3 期
Comparing the intravesical effect of gemcitabine with distilled water after trans urethral resection of tumor on prevention of recurrence in non-muscle-invasive bladder cancer
Oroumia University of Medical Sciences0 个研究点目标入组 134 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 134
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Patients with non-muscle-invasive bladder cancer
- •Patients candidate of trans urethral resection of tumor (TURT)
- •Tumor size less than or equal to 3 cm
- •Low grade tumor on cystoscopy
- •Diagnosed tumors in first time
排除标准
- •Frequent recurrence
- •Tumor size above 3 cm
研究者
相似试验
已完成
1 期
A phase I/II study of intravenous gemcitabine and nab-paclitaxel combined with intraperitoneal paclitaxel in pancreatic cancer patients with peritoneal metastasispancreatic cancer patients with peritoneal metastasisJPRN-UMIN000024148Department of Gastroenterology, The University of Tokyo53
进行中（未招募）
1 期
Phase I/II study of GnPipPTXJPRN-jRCTs031180095akai Yousuke44
已完成
2 期
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder CancerBladder CancerNCT01697306A.O.U. Città della Salute e della Scienza120
进行中（未招募）
不适用
ot availableTreatment of urinary tract infectionMedDRA version: 14.1Level: PTClassification code 10046571Term: Urinary tract infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: HLTClassification code 10046577Term: Urinary tract infectionsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-004594-82-BGSchur Pharmazeutika GmbH & Co. KG
已完成
不适用
A combination phase I/II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancerpreviously untreated elderly non-small cell lung cancerJPRN-C000000072West Japan Oncology Group25